Open Access

Downregulation of tumstatin expression by overexpression of ornithine decarboxylase

  • Authors:
    • Wei Wang
    • Chun-Xiao Xu
    • Guo-Sheng Hou
    • You-Gen Chen
    • Jia-Xuan Xin
    • Xian-Xi Liu
  • View Affiliations

  • Published online on: August 29, 2013     https://doi.org/10.3892/or.2013.2708
  • Pages: 2042-2048
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Tumor angiogenesis, a pivotal process for cancer growth and metastasis, requires both upregulation of pro‑angiogenic molecules and downregulation of anti‑angiogenic molecules. Anti-angiogenesis therapy represents a promising way for cancer treatment. Tumstatin, a novel endogenous angiogenesis inhibitor, inhibits endothelial cell proliferation, pathological angiogenesis and tumor growth. Ornithine decarboxylase (ODC), overexpressed in various cancers, is associated with cell transformation, tumor invasion and angiogenesis. We found that the expression of tumstatin was suppressed in ODC-overexpressing human cancer cells and renal carcinoma tissues. We presumed that ODC overexpression may downregulate the expression of tumstatin. To be able to test this hypothesis, we generated HEK293 cells that overexpress ODC (ODC transfectants) and characterized the following experimental groups: PBS-treated group, mock transfectants, ODC transfectants, ODC transfectants transfected with pcDNA-ODCr (an antisense ODC-expressing plasmid) group and putrescine-treated group. The effect of ODC overexpression on tumstatin expression was examined by reverse transcriptase-polymerase chain reaction (RT-PCR), western blot analysis and dual luciferase reporter assay. ODC-overexpressing cells and putrescine-treated cells showed suppressed tumstatin mRNA and protein expression, and decreased tumstatin gene promoter activity. Thus, ODC overexpression suppresses the expression of tumstatin, which may provide fundamental evidence for the combination of anti-angiogenic therapy and conventional therapy for cancer treatment.
View Figures
View References

Related Articles

Journal Cover

November 2013
Volume 30 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang W, Xu C, Hou G, Chen Y, Xin J and Liu X: Downregulation of tumstatin expression by overexpression of ornithine decarboxylase. Oncol Rep 30: 2042-2048, 2013
APA
Wang, W., Xu, C., Hou, G., Chen, Y., Xin, J., & Liu, X. (2013). Downregulation of tumstatin expression by overexpression of ornithine decarboxylase. Oncology Reports, 30, 2042-2048. https://doi.org/10.3892/or.2013.2708
MLA
Wang, W., Xu, C., Hou, G., Chen, Y., Xin, J., Liu, X."Downregulation of tumstatin expression by overexpression of ornithine decarboxylase". Oncology Reports 30.5 (2013): 2042-2048.
Chicago
Wang, W., Xu, C., Hou, G., Chen, Y., Xin, J., Liu, X."Downregulation of tumstatin expression by overexpression of ornithine decarboxylase". Oncology Reports 30, no. 5 (2013): 2042-2048. https://doi.org/10.3892/or.2013.2708